Food News and Research

RSS

Bingo enhances cognitive performance in people with Alzheimer's and Parkinson's disease

Bingo, a popular activity in nursing homes, senior centers and assisted-living facilities, has benefits that extend well beyond socializing. Researchers found high-contrast, large bingo cards boost thinking and playing skills for people with cognitive difficulties and visual perception problems produced by Alzheimer's disease (AD) and Parkinson's disease (PD).

4 Jan 2012

Vioguard self-sanitizing computer keyboard receives FDA clearance

Vioguard today announced the U.S. Food & Drug Administration has cleared the company's first product, the Vioguard self-sanitizing computer keyboard, for use in healthcare settings.

4 Jan 2012

Expert offers tips to lose weight

It happens every year, millions of Americans make resolutions to lose weight. Most persons end that pledge after the first few weeks of the New Year but experts at My Weight Doctor® say it may be that people are trying too hard to make quick changes. The experts say that making small, gradual changes to boost your metabolism will lead to better habits.

4 Jan 2012

FDA approves CSL Behring's Berinert for treatment of HAE attacks

CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for self-administration of Berinert, C1 Esterase Inhibitor (Human), a pasteurized, nanofiltered therapy indicated for the treatment of acute attacks of hereditary angioedema (HAE), a rare and potentially fatal genetic disorder.

4 Jan 2012

Neogen develops new Reveal Q+ test for deoxynivalenol

Neogen Corporation has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.

4 Jan 2012

FDA approves Cyberonics re-designed AspireHC generator

Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.

4 Jan 2012

Arena, Eisai collaborate in response to FDA's lorcaserin Complete Response Letter

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that Arena has submitted its response to the Complete Response Letter (CRL) issued by the US Food and Drug Administration (FDA) following review of the lorcaserin New Drug Application (NDA).

4 Jan 2012

Landec second quarter revenues increase 16% to $81.6 million

Landec Corporation, today reported results for the second quarter and first half of fiscal year 2012. Revenues for the second quarter of fiscal year 2012 increased 16% to $81.6 million compared to revenues of $70.2 million for the second quarter of fiscal year 2011.

4 Jan 2012

Viewpoints: Giving states responsibility for 'essential benefits'; The cost of proton beam treatment; Health spending in 2012

The Obama administration surprised supporters and critics when it decided to let states define the "essential health benefits" that must be provided to their citizens under health care reform. ... Federal health officials will need to monitor developments during the transition period to make sure consumers and employers can easily compare the benefit packages offered by private insurers.

3 Jan 2012

Healthy eating at low prices this New Year from the Change4Life campaign

As a part of healthy living campaign four million recipe cards will be distributed to the public. More than a thousand supermarket stores across the country are offering discounts on healthy ingredients such as fruits and vegetables and low fat yoghurts as part of the Department of Health's “Change4Life” public health campaign.

3 Jan 2012

FDA sets Feb. 9 for ODAC meeting to review CTI's resubmitted pixantrone NDA

Cell Therapeutics, Inc. (CTI) announced today that on February 9, 2012 the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review CTI's resubmitted New Drug Application (NDA) for pixantrone for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL) in patients who failed two or more lines of prior therapy.

3 Jan 2012

Detoxing this January useless but a long term effort may help: British Liver Trust

While many believe in detoxifying their systems after the season of indulgence, the British Liver Trust warns regarding January detoxes and urges people to think about their long-term health instead.

2 Jan 2012

Pfizer’s Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

2 Jan 2012

FDA notes shortage of ADHD medicines

According to the U.S. Food and Drug Administration (FDA) drugs to treat attention deficit hyperactivity disorder (ADHD) are in such short supply that hundreds of patients complain daily to the agency that they are unable to find a pharmacy with enough pills to fill their prescriptions.

2 Jan 2012

Issue of NCDs in post-conflict countries must be addressed, say experts

Countries recovering from war are at risk of being left to their own devices in tackling non communicable diseases, leaving an "open door" for exploitation by alcohol, tobacco and food companies, health experts warn.

2 Jan 2012

Similar sounding drug names should come with warnings

There have been mix ups and medication errors with similar sounding names of drugs - eye drops called Durezol and salicylic acid-containing wart remedy Duresal for example.

1 Jan 2012

FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older

Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.

31 Dec 2011

Poll surveys New Year resolutions on weight loss and smoking

Roughly one-third of Americans say they have made a New Year's resolution to lose weight in the last five years and 42 percent of people who said they smoke regularly in that timeframe pledged to quit the habit, according to the Thomson Reuters-NPR Health Poll.

31 Dec 2011

CATCH Healthy Habits program will come to Albany in early 2012

Remember riding your bicycle all over town until dark and then coming home to a hot, healthy meal your mom prepared? Lots of adults do, and now many of them are volunteering to help the next generation – and in the process themselves – get and stay healthy through an innovative program called CATCH Healthy Habits.

31 Dec 2011

ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program

ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.

31 Dec 2011